Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3342770

QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    5.3.2014
  • EP published:
    30.3.2022
  • EP application number:
    17179729.3
  • Max expiry date:
    4.3.2034
  • Title in English:
    QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR
  • Language of the patent:
    English

Timeline

Today
5.3.2014EP application
30.3.2022EP Publication

Owner

  • Name:
    AstraZeneca AB
  • Address:
    151 85 Södertälje, SE

Inventor

  • Name:
    LI, David, Yunzhi
  • Address:
    Zhangjiang Hi-Tech Park, Shanghai 201203, CN
  • Name:
    WANG, Jiabing
  • Address:
    Zhangjiang Hi-Tech Park, Shanghai 201203, CN
  • Name:
    YANG, Zhenfan
  • Address:
    Zhangjiang Hi-Tech Park, Shanghai 201203, CN
  • Name:
    ZENG, Qinbei
  • Address:
    Zhangjiang Hi-Tech Park, Shanghai 201203, CN
  • Name:
    ZHANG, Xiaolin
  • Address:
    Zhangjiang Hi-Tech Park, Shanghai 201203, CN

Priority

  • Number:
    PCT/CN2013/072250
  • Date:
    6.3.2013
  • Country:
    WO

Classification

  • Categories:
    C07D 403/12, A61K 31/517, A61P 35/00

Upload documents